SBOT - Stellar Biotechnologies, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue228.2871,271.689758.689
Cost of Revenue534.4531,127.828840.247
Gross Profit-306.166143.861-81.558
Operating Expenses
Research Development1,973.41,729.4451,029.489
Selling General and Administrative2,944.983,322.7723,227.545
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-5,224.546-4,908.356-4,338.592
Income from Continuing Operations
Total Other Income/Expenses Net194.698-110.5241,532.363
Earnings Before Interest and Taxes-5,029.848-5,018.88-2,806.229
Interest Expense---
Income Before Tax-5,029.848-5,018.88-2,806.229
Income Tax Expense0.87.236.8
Minority Interest---
Net Income From Continuing Ops-5,030.648-5,026.08-2,843.029
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-5,030.648-5,026.08-2,843.029
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-5,030.648-5,026.08-2,843.029